118 related articles for article (PubMed ID: 12218603)
1. Congenital dyserythropoietic anemia, type 1, in a polynesian patient: response to interferon alpha2b.
Roda L; Pasche J; Fournier A; Terorotua V; Wickramasinghe SN; Tamary H; Schischmanoff PO; Tchernia G; Delaunay J
J Pediatr Hematol Oncol; 2002; 24(6):503-6. PubMed ID: 12218603
[TBL] [Abstract][Full Text] [Related]
2. Interferon therapy in congenital dyserythropoietic anemia type I/II.
Marwaha RK; Bansal D; Trehan A; Garewal G
Pediatr Hematol Oncol; 2005 Mar; 22(2):133-8. PubMed ID: 15804998
[TBL] [Abstract][Full Text] [Related]
3. Severe congenital dyserythropoietic anaemia type I: prenatal management, transfusion support and alpha-interferon therapy.
Parez N; Dommergues M; Zupan V; Chambost H; Fieschi JB; Delaunay J; Miélot F; Cramer EM; Dommergues JP; Wickramasinghe SN; Tchernia G
Br J Haematol; 2000 Aug; 110(2):420-3. PubMed ID: 10971401
[TBL] [Abstract][Full Text] [Related]
4. alpha-Interferon therapy for congenital dyserythropoiesis type I.
Lavabre-Bertrand T; Blanc P; Navarro R; Saghroun M; Vannereau H; Braun M; Wagner A; Taïb J; Lavabre-Bertrand C; Navarro M
Br J Haematol; 1995 Apr; 89(4):929-32. PubMed ID: 7772538
[TBL] [Abstract][Full Text] [Related]
5. Congenital dyserythropoietic anemia type 1 with fetal onset of severe anemia.
Kato K; Sugitani M; Kawataki M; Ohyama M; Aida N; Koga N; Ijiri R; Imaizumi K; Kigasawa H; Tanaka Y; Itani Y
J Pediatr Hematol Oncol; 2001 Jan; 23(1):63-6. PubMed ID: 11196275
[TBL] [Abstract][Full Text] [Related]
6. Successful management of congenital dyserythropoietic anemia type I with interferon alpha in a child.
Yarali N; Fişgin T; Duru F; Atilla P; Müftüoğlu SF; Kaymaz SF
Pediatr Hematol Oncol; 2005 Jun; 22(4):265-70. PubMed ID: 16020112
[TBL] [Abstract][Full Text] [Related]
7. Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.
Rathe M; Møller MB; Greisen PW; Fisker N
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29049846
[TBL] [Abstract][Full Text] [Related]
8. Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I.
Lavabre-Bertrand T; Ramos J; Delfour C; Henry L; Guiraud I; Carillo S; Wagner A; Bureau JP; Blanc P
Eur J Haematol; 2004 Nov; 73(5):380-3. PubMed ID: 15458519
[TBL] [Abstract][Full Text] [Related]
9. Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy.
Goede JS; Benz R; Fehr J; Schwarz K; Heimpel H
Ann Hematol; 2006 Sep; 85(9):591-5. PubMed ID: 16767397
[TBL] [Abstract][Full Text] [Related]
10. Treatment of transfusion-dependent congenital dyserythropoietic anemia Type I patients with pegylated interferon alpha-2a.
Abu-Quider A; Asleh M; Shalev H; Fruchtman Y; Ben-Harosh M; Beck G; Kapelushnik J
Eur J Haematol; 2020 Aug; 105(2):216-222. PubMed ID: 32302424
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I.
Shamseddine A; Taher A; Jaafar H; Haidar JH; Nasr R; Arzoumanian V; Salem Z; Bazarbachi A
Eur J Haematol; 2000 Sep; 65(3):207-9. PubMed ID: 11007058
[TBL] [Abstract][Full Text] [Related]
12. Effects of four species of interferon-alpha on cultured erythroid progenitors from congenital dyserythropoietic anaemia type I.
Menike D; Wickramasinghe SN
Br J Haematol; 1998 Dec; 103(3):825-30. PubMed ID: 9858239
[TBL] [Abstract][Full Text] [Related]
13. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation.
Heimpel H; Schwarz K; Ebnöther M; Goede JS; Heydrich D; Kamp T; Plaumann L; Rath B; Roessler J; Schildknecht O; Schmid M; Wuillemin W; Einsiedler B; Leichtle R; Tamary H; Kohne E
Blood; 2006 Jan; 107(1):334-40. PubMed ID: 16141353
[TBL] [Abstract][Full Text] [Related]
14. An aberrant type of congenital dyserythropoietic anemia associated with a beta-thalassemia trait.
Sansone G; Lupi L
Ann Hematol; 1991 May; 62(5):184-7. PubMed ID: 2049466
[TBL] [Abstract][Full Text] [Related]
15. Neonatal manifestations of congenital dyserythropoietic anemia type I.
Shalev H; Tamary H; Shaft D; Reznitsky P; Zaizov R
J Pediatr; 1997 Jul; 131(1 Pt 1):95-7. PubMed ID: 9255198
[TBL] [Abstract][Full Text] [Related]
16. Response of CDA type I to alpha-interferon.
Wickramasinghe SN
Eur J Haematol; 1997 Feb; 58(2):121-3. PubMed ID: 9111594
[No Abstract] [Full Text] [Related]
17. Response to Alpha-Interferon Treatment of the Congenital Dyserythropoietic Anemia type I in Two Sicilian Beta Thalassemia Carriers.
Agrigento V; Barone R; Sclafani S; Di Maggio R; Sacco M; Maggio A; D'Alcamo E
Indian J Hematol Blood Transfus; 2017 Dec; 33(4):621-623. PubMed ID: 29075082
[TBL] [Abstract][Full Text] [Related]
18. Type I congenital dyserythropoietic anemia (CDA I): ultrastructural findings.
Dell'Orbo C; Marchi A; Monafo V; Scotta MS; Sacchi F; Granata A; Quacci D
Haematologica; 1983; 68(1):30-7. PubMed ID: 6404705
[No Abstract] [Full Text] [Related]
19. A new type of transfusion-dependent congenital dyserythropoietic anemia.
Heimpel H; Kohne E; Schrod L; Schwarz K; Wickramasinghe S
Haematologica; 2007 Oct; 92(10):1427-8. PubMed ID: 18024378
[TBL] [Abstract][Full Text] [Related]
20. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.
Heimpel H; Anselstetter V; Chrobak L; Denecke J; Einsiedler B; Gallmeier K; Griesshammer A; Marquardt T; Janka-Schaub G; Kron M; Kohne E
Blood; 2003 Dec; 102(13):4576-81. PubMed ID: 12933587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
